This study aims to explore the effects of miR‐92a on tumor growth and immune function of cervical cancer by targeting PTEN via the MAPK/ERK signaling pathway in U14 cervical cancer mouse models. The gene discussed is MAPK1; the disease is cervical carcinoma.